Ketamine and Psychedelic Therapy Near You in Seattle, WA

How to find ketamine care and a psychedelic therapist in Seattle

The fastest way to find ketamine treatment near you in Seattle is to choose between two paths: an in-person clinic or an at-home telehealth program. Both are legal and available across Washington.

In-person clinics in the Seattle area provide IV or intramuscular ketamine infusions, and at some sites Spravato (esketamine). You book a consultation, then travel to the clinic for each monitored session. Local ketamine providers include The Ketamine Clinic of Seattle and Northwest Ketamine Clinics, with others across the Eastside and south toward Tacoma.

The at-home path is what most people mean when they search for a psychedelic therapist near me, or ask where they can get psychedelic-assisted therapy. With Mindbloom, eligible adults complete an online clinical evaluation, and if a licensed clinician approves, receive prescribed ketamine and a guided program they do from home anywhere in Washington. No waitlist for a local chair, no commute.

Because ketamine is a prescription medical treatment, every path starts with a clinician confirming you are a good fit. At-home ketamine therapy in Washington is not available on demand. It begins with that evaluation.

Ketamine and psychedelic therapy across the Seattle metro

Ketamine care reaches the whole Seattle metro, not just the city core. In-clinic providers operate in Seattle proper and across the wider region, and Mindbloom's at-home program covers every community in the area.

That includes Bellevue, Redmond, and Kirkland on the Eastside, Tacoma and Kent to the south, Renton, and Everett to the north. Wherever you are in the metro, at-home ketamine therapy removes the drive: the same guided program arrives at your door. Searches like ketamine therapy Bellevue or psychedelic therapy Tacoma resolve to the same reality, a handful of local clinics for in-person infusions, and statewide at-home access through Mindbloom.

Your ketamine and psychedelic therapy options in Seattle

There are three real ketamine options in the Seattle area, plus the psychedelics people ask about that are not yet available for therapy here.

If you came here searching for a psychedelic therapist or psilocybin therapy in Washington, here is the straight answer. Psilocybin, MDMA, LSD, and ayahuasca are not legally available for therapy in Washington, and MDMA-assisted therapy is not FDA-approved. That is why ketamine is the psychedelic-class therapy you can actually begin now. It also holds up on results: Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37 to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.⁶ ¹³

The practical difference between the options is access. In-clinic IV ketamine means booking, driving, and paying out of pocket for each monitored infusion. Mindbloom delivers a comparable psychedelic-class experience at home. If you are weighing the two, see how at-home ketamine compares with IV.

What ketamine therapy can help with

Depression is the flagship use of ketamine therapy, and Mindbloom's primary indication. If you are searching for ketamine treatment for depression near you in Seattle, that is the core of what this therapy addresses.

Mindbloom also supports anxiety, PTSD, grief, burnout, and sleep, the conditions its own published research covers. PTSD is a particular strength: Mindbloom is the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes. Ketamine is used off-label for several of these, and a clinician confirms whether it fits your situation.

Mindbloom's psychedelic therapy programs and outcomes

Mindbloom has delivered more than 800,000 guided at-home sessions and is one of the largest at-home psychedelic-therapy providers. Its outcomes are peer-reviewed: a subcutaneous study (Parks 2026) reporting depression, anxiety, and PTSD results in one dataset, alongside two earlier peer-reviewed studies of its sublingual protocol, plus research preprints extending the evidence to grief, burnout, and sleep. It is the largest published evidence base in at-home ketamine therapy.

_{About these figures: Individual results vary.
⁶ Subcutaneous, six-session course (Parks AC et al. J Med Internet Res. 2026). Response = at least a 50% reduction (PHQ-9 or GAD-7) or a 10-point reduction (PCL-5); remission = final PHQ-9 or GAD-7 below 5, or a 10-point reduction with PCL-5 below 33.
⁷ Swain et al. 2026 (grief, PGD-13), n=503.
⁸ Swain et al. (burnout, MBI-GS), n=395.
⁹ Swain et al. 2026 (sleep, PHQ-9 Item 3), n=13,963. Single-item measure; ketamine is off-label for sleep.
ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0).}

Mindbloom offers tailored programs built with mental-health thought leaders that use the psychedelic modality to address specific outcomes, not just prescribe medication for them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

How those outcomes compare, each against a specific published study rather than a whole field:

• Mindbloom's reported depression response is comparable to the rate reported in a study of first-line SSRIs, without a daily medication and faster (2 sessions vs four to six weeks).⁶ ¹⁰
• Mindbloom's reported anxiety response rate is about 29% higher than the rate reported in a study of CBT for generalized anxiety (60.6% vs 47%), in about half the time.⁶ ¹¹
• Mindbloom's reported at-home PTSD response rate exceeds the rate reported in the leading repeated-infusion IV ketamine trial (76.7% vs 67%).⁶ ¹²

Comparisons are to specific published studies, not entire treatment categories, and individual results vary.

Is ketamine and psychedelic therapy legal in Washington?

Yes for ketamine. Ketamine is an FDA-approved Schedule III medication that a licensed clinician can prescribe, and it is available now in Washington both in clinics and at home. Is ketamine legal in Washington is, in practice, a settled question: it is.

Psilocybin is a different story. It remains illegal statewide in Washington, classified Schedule I, with no licensed psilocybin program.² Seattle drew national attention when its City Council unanimously passed Resolution 32021 in 2021, becoming the largest US city at the time to deprioritize enforcement of laws against entheogens such as psilocybin.³ King County followed with a similar motion in March 2026.⁴ Both are worth reading clearly: they direct local police to treat personal entheogen use as a low priority, but they are not legalization and offer no legal protection under state or federal law. There is no licensed place to receive psilocybin therapy in Washington.

A medical-psilocybin bill was advancing in the state legislature in early 2026 but has not become law, and any program it might create would be years away. For now, the psychedelic-class therapy you can legally and reliably start in Seattle is ketamine, and with Mindbloom you can start it from home.

For wider context, Washington ranks 20th of 51 states and DC for mental health access, upper-middle nationally.¹ In-person psychedelic-class care is still limited and mostly out of pocket, which is part of why at-home ketamine has grown.

How at-home ketamine therapy works with Mindbloom

The process is built around safety and support. You begin with an online evaluation. A licensed clinician reviews your history and mental health and decides whether ketamine therapy is appropriate. If approved, Mindbloom ships prescribed ketamine and pairs you with a program and guides.

Sessions happen at home. You prepare your space, a treatment monitor is present or reachable, and you follow a clinician-guided schedule. Frequency is personalized rather than fixed, and many people notice some rapid relief early while the benefits build cumulatively over the program.

Who it is for. Ketamine therapy is for eligible adults and is not right for everyone. A clinician screens for conditions and medications that could make it unsafe. That medical gatekeeping is a feature, not a formality.

Cost and insurance. Mindbloom costs $165 to $215 per session within a multi-session program, and many clients use HSA or FSA funds; some use out-of-network reimbursement. See current pricing. In-clinic IV ketamine in Seattle is typically higher and paid out of pocket. Spravato may be covered by insurance for people who qualify, subject to the insurer's prior authorization; otherwise it is out of pocket.

Working with your therapist. Mindbloom's clinicians and guides can work alongside your existing therapist. Many clients continue their own talk therapy and use ketamine sessions to deepen that work. If you are an eligible adult in the Seattle area, the process begins with an online clinician evaluation.